KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 114 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $192,000 | +6.1% | 12,410 | 0.0% | 0.03% | 0.0% |
| Q3 2020 | $181,000 | -61.5% | 12,410 | -50.0% | 0.03% | -63.6% |
| Q2 2020 | $470,000 | -1.5% | 24,810 | 0.0% | 0.08% | -11.5% |
| Q1 2020 | $477,000 | +0.2% | 24,810 | 0.0% | 0.09% | +35.9% |
| Q4 2019 | $476,000 | -0.6% | 24,810 | -50.2% | 0.06% | -7.2% |
| Q3 2019 | $479,000 | -81.9% | 49,810 | -88.7% | 0.07% | -81.7% |
| Q2 2019 | $2,642,000 | -25.9% | 440,994 | -27.8% | 0.38% | -22.3% |
| Q1 2019 | $3,567,000 | +123.8% | 610,850 | +259.2% | 0.48% | +101.2% |
| Q4 2018 | $1,594,000 | – | 170,081 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,200,396 | $30,084,000 | 1.72% |
| TFS CAPITAL LLC | 105,040 | $987,000 | 0.26% |
| Tekla Capital Management LLC | 500,324 | $4,703,000 | 0.20% |
| Piermont Capital Management Inc. | 51,080 | $480,000 | 0.11% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 55,793 | $524,000 | 0.09% |
| Candriam S.C.A. | 390,000 | $3,666,000 | 0.08% |
| Virtus ETF Advisers LLC | 27,446 | $258,000 | 0.08% |
| SECOR Capital Advisors, LP | 66,484 | $625,000 | 0.08% |
| Trexquant Investment LP | 29,007 | $273,000 | 0.04% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 32,196 | $303,000 | 0.04% |